Insider NameBuy/SellCompany NameTickerAmountShares Change
Jun 03, 2025Jun 03, 2025Esposito Pamela
Dir
SellKymera Therapeutics, Inc.KYMR$49.04$245,186-0
Dec 02, 2024Dec 03, 2024Esposito Pamela
Dir
SellKymera Therapeutics, Inc.KYMR$49$122,500-0
Sep 17, 2024Sep 17, 2024Esposito Pamela
Dir
SellKymera Therapeutics, Inc.KYMR$48.28$651,766-0
Sep 11, 2023Sep 14, 2023Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$20.01$113,214-2.10%
Aug 22, 2023Aug 25, 2023Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$20.01$372,186-6.59%
Aug 11, 2023Aug 16, 2023Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$20$28,000-0.53%
Jul 10, 2023Jul 12, 2023Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$21.58$431,541-7.06%
May 16, 2023May 19, 2023Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$18.05$107,686-2.21%
Dec 09, 2022Dec 14, 2022Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$25.03$375,450-6.14%
May 16, 2022May 18, 2022Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$14.59$51,167-1.51%
Aug 04, 2021Aug 07, 2021Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$35.08$1M-12.49%
Jul 20, 2021Jul 23, 2021Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$33.14$576,575-7.65%
Jul 15, 2021Jul 20, 2021Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$33.37$153,502-2.14%
Jan 14, 2021Jul 20, 2021Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$43.99$2M-23.81%
Jan 14, 2021Jan 20, 2021Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$43.99$2M-23.81%
Oct 14, 2020Oct 16, 2020Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$32.9$526,410-12.43%
Aug 31, 2020Sep 01, 2020Esposito Pamela
Chief Business Officer
SellReplimune Group, Inc.REPL$27.05$135,250-4.25%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.